Study of Capmatinib in Chinese Adult Patients With Advanced Non-small Cell Lung Cancer Harboring MET Exon 14 Skipping Mutation
Clinical trial NCT04677595 · COMPLETED
Trial details
- NCT number
- NCT04677595
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-17
- Primary completion
- 2023-10-12
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.